Roche expanding capacity 40% across network, but will still use CMOs
Roche is expanding its manufacturing operations to service its biologics pipeline, but the firm says it will continue to outsource approximately 20% of all production.
Roche is expanding its manufacturing operations to service its biologics pipeline, but the firm says it will continue to outsource approximately 20% of all production.
Patheon has sold a production plant in Italy to LIVIA and agreed to a management buyout at a site in Austria as it prepares to go public.
AmerisourceBergen has reported a good third quarter driven by an acquisition and a JV, but says stunted generic prices will slow income in 2016.